Global Information would like to present a new market research report, "Global Markets for Drug-Device Combinations" by BCC Research.
The global market for drug-device combinations was valued at approximately $13.7 billion in 2009. According to researchers at BCC, the drug-device combinations global market is forecasted to rise at a compound annual growth rate (CAGR) of 14.5% to reach $27 billion by the end of 2014. BCCs study primarily covers devices that serve a therapeutic function and have a drug component incorporated into them. The report also includes an overview of the current drug-device combination product market and provides insight into the sizable emerging market segments of this industry.
Global market projections for the drug-device combinations industry can be also be divided into various segments:
- The coronary stents segment is expected to increase to $7.4 billion at a compound annual growth rate of 9% through 2014.
- The photodynamics therapy segment is expected to reach $2.6 billion, growing at a compound annual growth rate of 11.6% through 2014.
- The antimicrobial catheters segment is forecasted to grow at a compound annual growth rate of 11.1% and reach $2.2 billion in 2014.
- The orthopedic applications segment is projected to reach $1.8 billion, growing at a compound annual growth rate of 8.4% through 2014.